Review



s ace2 interaction  (BPS Bioscience)


Bioz Verified Symbol BPS Bioscience is a verified supplier
Bioz Manufacturer Symbol BPS Bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    BPS Bioscience s ace2 interaction
    S Ace2 Interaction, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/s+ace2+interaction/SARS-CoV-1+Spike+Trimer+(S1%2BS2)%3AACE2+Inhibitor+Screening+Colorimetric+Assay+Kit/pmc12177760-190-12-14
    Average 94 stars, based on 2 article reviews
    s ace2 interaction - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Screening Assay:

    Article Title: In Silico Discovery of a Novel Antiviral Scaffold for SARS-CoV‑2 Targeting the Spike Glycoprotein through the Fatty Acid Binding Pocket
    Article Snippet: .. An inhibitor screening assay kit was used to screen inhibitors of the S-ACE2 interaction (BPS Bioscience catalog no. 78012). .. The kit includes the S protein in its native trimeric conformation from the Wuhan strain, providing the best physiologically relevant model for this interaction.

    Article Title: Disrupting SARS-CoV-2 Spike Protein Activity: A Virtual Screening and Binding Assay Study
    Article Snippet: .. An Inhibitor Screening Assay Kit was used to screen inhibitors of the S–ACE2 interaction (BPS Bioscience Catalog # 78012) [30]. ..

    Article Title: In Silico Discovery of a Novel Antiviral Scaffold for SARS-CoV-2 Targeting the Spike Glycoprotein through the Fatty Acid Binding Pocket
    Article Snippet: .. An inhibitor screening assay kit was used to screen inhibitors of the S-ACE2 interaction (BPS Bioscience catalog no. 78012).49 The kit includes the S protein in its native trimeric conformation from the Wuhan strain, providing the best physiologically relevant model for this interaction.50 The assay kit also contains biotinylated-ACE2, streptavidin-HRP, and the assay buffers. ..

    Article Title: Disrupting SARS-CoV-2 Spike Protein Activity: A Virtual Screening and Binding Assay Study
    Article Snippet: .. An Inhibitor Screening Assay Kit was used to screen inhibitors of the S–ACE2 interaction (BPS Bioscience Catalog # 78012) [ ]. ..



    Similar Products

    94
    BPS Bioscience s ace2 interaction
    S Ace2 Interaction, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/s+ace2+interaction/SARS-CoV-1+Spike+Trimer+(S1%2BS2)%3AACE2+Inhibitor+Screening+Colorimetric+Assay+Kit/pmc12177760-190-12-14
    Average 94 stars, based on 1 article reviews
    s ace2 interaction - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    F1000Research sarscov-2 s protein–ace2 interaction
    Sarscov 2 S Protein–Ace2 Interaction, supplied by F1000Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/s+ace2+interaction/therapeutic+protein/ppr0335166-17-7-20
    Average 90 stars, based on 1 article reviews
    sarscov-2 s protein–ace2 interaction - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    99
    Gilead Sciences ace2 viral spike s protein interaction several candidate therapeutics
    <t>ACE2</t> is a key enzyme in the RAS, catalyzing the metabolism of Ang II to Ang(1-7) and Ang I to Ang(1-9). ACE2 also mediates degradation of ACE-catalyzed breakdown products, Des-arg9-Bk (B1R agonist) and Lys-des-arg9-Bk. The net result of ACE2 in these two systems is to counterbalance ACE/Ang II/AT1R and Bradykinin/Des-arg9-Bk/B1R pathways. Through its cellular binding and entry mechanisms, SARS-CoV-2 is proposed to result in a reduction of ACE2, leading to elevations in Ang I and II, and leading to AT1R stimulation, and Des-arg9-Bk leading to B1R stimulation thus exacerbating inflammation, vascular leakage, and pro-fibrotic events. Potential therapeutics include those targeted to angiotensin and bradykinin system related peptides, in addition to peptides targeting the ACE2-viral spike (S) protein interaction
    Ace2 Viral Spike S Protein Interaction Several Candidate Therapeutics, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/s+ace2+interaction/VEKLURY/pmc07652589-40-18-33
    Average 99 stars, based on 1 article reviews
    ace2 viral spike s protein interaction several candidate therapeutics - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    ACE2 is a key enzyme in the RAS, catalyzing the metabolism of Ang II to Ang(1-7) and Ang I to Ang(1-9). ACE2 also mediates degradation of ACE-catalyzed breakdown products, Des-arg9-Bk (B1R agonist) and Lys-des-arg9-Bk. The net result of ACE2 in these two systems is to counterbalance ACE/Ang II/AT1R and Bradykinin/Des-arg9-Bk/B1R pathways. Through its cellular binding and entry mechanisms, SARS-CoV-2 is proposed to result in a reduction of ACE2, leading to elevations in Ang I and II, and leading to AT1R stimulation, and Des-arg9-Bk leading to B1R stimulation thus exacerbating inflammation, vascular leakage, and pro-fibrotic events. Potential therapeutics include those targeted to angiotensin and bradykinin system related peptides, in addition to peptides targeting the ACE2-viral spike (S) protein interaction

    Journal: Molecular Medicine

    Article Title: SARS-CoV-2 and interferon blockade

    doi: 10.1186/s10020-020-00231-w

    Figure Lengend Snippet: ACE2 is a key enzyme in the RAS, catalyzing the metabolism of Ang II to Ang(1-7) and Ang I to Ang(1-9). ACE2 also mediates degradation of ACE-catalyzed breakdown products, Des-arg9-Bk (B1R agonist) and Lys-des-arg9-Bk. The net result of ACE2 in these two systems is to counterbalance ACE/Ang II/AT1R and Bradykinin/Des-arg9-Bk/B1R pathways. Through its cellular binding and entry mechanisms, SARS-CoV-2 is proposed to result in a reduction of ACE2, leading to elevations in Ang I and II, and leading to AT1R stimulation, and Des-arg9-Bk leading to B1R stimulation thus exacerbating inflammation, vascular leakage, and pro-fibrotic events. Potential therapeutics include those targeted to angiotensin and bradykinin system related peptides, in addition to peptides targeting the ACE2-viral spike (S) protein interaction

    Article Snippet: Potential therapeutics include those targeted to angiotensin and bradykinin system related peptides, in addition to peptides targeting the ACE2-viral spike (S) protein interaction Several candidate therapeutics focus on the virus, targeting viral replication (remdesivir), viral entry (Arbidol, APN01, convalescent plasma, monoclonal antibodies (REGN-COV2), camostat mesylate), or critical viral proteins (protease inhibitors).

    Techniques: Binding Assay